School of Pharmacy, University of Washington, Seattle, USA.
Melinta Therapeutics, Morristown, USA.
Int J Infect Dis. 2022 Sep;122:1041-1043. doi: 10.1016/j.ijid.2022.07.073. Epub 2022 Aug 3.
This case report describes a patient with post-neurosurgical infection and bacteremia caused by Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae. There is limited evidence to guide antibiotic treatment decisions for such infections. The patient was treated with meropenem-vaborbactam (MEV). MEV monotherapy was associated with bacteremia clearance.
本病例报告描述了一例神经外科手术后感染和血流感染的患者,感染由产碳青霉烯酶肺炎克雷伯菌引起。对于此类感染,抗生素治疗决策的指导证据有限。患者接受了美罗培南-维巴坦(MEV)治疗。MEV 单药治疗与菌血症清除相关。